Frequently Asked Questions
The market is segmented based on Global Self-Monitoring of Blood Glucose (SMBG) Market, By Product (Test Strips, Lancets, Blood Glucose Meters, Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors), Applications (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), End User (Hospitals, Home Settings, and Diagnostic Centres), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
.
The Global Self Monitoring Of Blood Glucose Smbg Market size was valued at USD 16825.05 USD Million in 2020.
The Global Self Monitoring Of Blood Glucose Smbg Market is projected to grow at a CAGR of 5.23% during the forecast period of 2021 to 2028.
The major players operating in the market include B. Braun Melsungen AG, Bionime Corporation, F. Hoffmann La Roche Ltd, Medtronic, Bayer AG, Abbott, LifeScan IP Holdings LLC, AgaMatrix, 77 Elektronika Kft, Trividia Health , Dexcom , Ascensia Diabetes Care Holdings AG, EDAN Instruments , Yu Yue medical, Merck KGaA, Johnson & Johnson Private Limited, BD, Terumo Corporation, PHC Holdings Corporation, Trividia Health .
